National Barrett’s Registry Boosts Early Detection of Esophageal Cancer

A structured Barrett’s program has empowered early diagnosis and treatment of esophageal adenocarcinoma (EAC), revealing a 4.7% incidence rate of high-grade dysplasia (HGD) and EAC among patients. Over 9,400 patients were monitored, with a median follow-up of 4.4 years. Key risk factors for progression included age, male gender, and Barrett’s length. This initiative anticipates reduced mortality through quality-assured surveillance and eradication therapies, achieving 100% cancer-specific survival.